PL145636B1 - Method of obtaining isothiouronian salts - Google Patents

Method of obtaining isothiouronian salts Download PDF

Info

Publication number
PL145636B1
PL145636B1 PL1985252744A PL25274485A PL145636B1 PL 145636 B1 PL145636 B1 PL 145636B1 PL 1985252744 A PL1985252744 A PL 1985252744A PL 25274485 A PL25274485 A PL 25274485A PL 145636 B1 PL145636 B1 PL 145636B1
Authority
PL
Poland
Prior art keywords
aminoiminomethyl
compounds
general formula
isothiouronium
allyl
Prior art date
Application number
PL1985252744A
Other languages
English (en)
Polish (pl)
Other versions
PL252744A1 (en
Original Assignee
Peremartoni Vegyipari Vallalat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU841324A external-priority patent/HU196745B/hu
Application filed by Peremartoni Vegyipari Vallalat filed Critical Peremartoni Vegyipari Vallalat
Publication of PL252744A1 publication Critical patent/PL252744A1/xx
Publication of PL145636B1 publication Critical patent/PL145636B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
PL1985252744A 1984-04-03 1985-04-03 Method of obtaining isothiouronian salts PL145636B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU841324A HU196745B (en) 1984-04-03 1984-04-03 Process for producing n-/amino-imino-methyl/-isothiuronium derivatives with immunostimulant and cytostatic effect
HU132485 1985-03-19

Publications (2)

Publication Number Publication Date
PL252744A1 PL252744A1 (en) 1986-08-12
PL145636B1 true PL145636B1 (en) 1988-10-31

Family

ID=26317358

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1985252744A PL145636B1 (en) 1984-04-03 1985-04-03 Method of obtaining isothiouronian salts

Country Status (8)

Country Link
JP (1) JPH0825992B2 (ja)
CN (1) CN1008093B (ja)
DE (1) DE3590133T1 (ja)
FI (1) FI80259C (ja)
GB (1) GB2167750B (ja)
IL (1) IL74743A (ja)
NZ (1) NZ211639A (ja)
PL (1) PL145636B1 (ja)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR788429A (fr) * 1934-12-14 1935-10-10 Ig Farbenindustrie Ag Production de combinaisons du guanyle et biguanyle
DE2426683A1 (de) * 1974-06-01 1975-12-18 Boehringer Mannheim Gmbh Biguanide und verfahren zu deren herstellung

Also Published As

Publication number Publication date
FI80259B (fi) 1990-01-31
DE3590133T1 (de) 1986-06-26
PL252744A1 (en) 1986-08-12
GB8529529D0 (en) 1986-01-08
FI854790A0 (fi) 1985-12-03
GB2167750A (en) 1986-06-04
GB2167750B (en) 1988-04-27
CN1008093B (zh) 1990-05-23
IL74743A0 (en) 1985-06-30
CN85103160A (zh) 1986-09-17
JPS61501849A (ja) 1986-08-28
FI854790L (fi) 1985-12-03
NZ211639A (en) 1989-03-29
FI80259C (fi) 1990-05-10
IL74743A (en) 1992-09-06
JPH0825992B2 (ja) 1996-03-13

Similar Documents

Publication Publication Date Title
PL145420B1 (en) Method of obtaining novel substituted polycarbocyclic aromatic amine alkanoles
JPS58174319A (ja) 薬剤組成物
DK162840B (da) Zink(ii)-komplekser af substituerede 3-hydroxypyroner eller 3-hydroxypyridoner, anvendelse af disse samt farmaceutiske praeparater indeholdende disse
RU2324688C2 (ru) Производные бисбензизоселеназолонила с противоопухолевым, противовоспалительным и антитромботическим действием и их применение
AU621431B2 (en) Castanospermine esters in the inhibition of tumor metastasis
KR860001865B1 (ko) 2'-데옥시-5-치환 우리딘 유도체의 제조방법
US5023261A (en) Acylated benzofuro[3,2-c]quinoline compounds with utility as treatments for osteoporosis
HUT67899A (en) Thioxanthenone antitumor agents
EP1043316B1 (en) Nitroimidazole derivatives as sensitivity enhancers for chemotherapy and radiotherapy
US4130648A (en) 5-Fluorouracil derivatives and antitumor preparations containing the same
JPS5962584A (ja) コクシジユ−ム症に対して活性なキナゾリノン誘導体
FI80259B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara isotiuronium-salter.
US4710578A (en) Isothiuronium salts
US4314076A (en) Cystamine derivatives suitable for use as medicaments
FI75809B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva vattenloesliga derivat av 6,6'-metylen-bis(2,2,4- trimetyl-1,2-dihydrokinolin).
US5091410A (en) Thioxanthenone antitumor agents
US4939156A (en) New tetramethyl-cis-diaza-bicyclo{4.2.0}octane-3,5-dione derivatives having differentiation-inducing activity and antiviral activity
US4510147A (en) Compositions for and medical use of water-soluble derivatives of 6,6-methylene-bis-(2,2,4-trimethyl-1,2-dihydroquinoline)
EP0293146A1 (en) Benzofuro [3,2-c] quinoline compounds
SU1085204A1 (ru) 4,9-БИС-АМИНОПРОИЗВОДНЫЕ ДИПИРИМИДО-5Н-(4,5-в)-(4',5 '-е)-(1,4) ТИАЗИНА, ОБЛАДАЮЩИЕ ЦИТОСТАТИЧЕСКИМ, ПРОТИВООПУХОЛЕВЫМ И АНТИРЕДУКТАЗНЫМ ДЕЙСТВИЕМ
SU1001855A3 (ru) Способ получени 2-замещенных-1н-фенантро[9,10- @ ]имидазолов или их солей
US3957978A (en) Phosphonium anti-parasitics
US4046897A (en) 5-Mercaptopyridoxine alkanesulfonates and methods of use and pharmaceutical compositions
KR100377138B1 (ko) 퓨린구조를갖는싸이클린의존키나아제저해제,그제조방법및그를함유하는항암제조성물
JPS61172894A (ja) ［α，ω‐ビス（ジフエニルホスフイノ）炭化水素］ビス［（チオ糖）金］およびビス［（セレノ糖）金］誘導体